What is Evommune 's invested capital?

Evommune (EVMN) reported invested capital of -$3.58M in Q1 2026.

What is the long-term trend for Evommune 's invested capital?

Over 2 years (2023 to 2025), Evommune 's invested capital has grown at a -33.0% compound annual growth rate (CAGR), from $2.05M to $919.1K.

What does invested capital mean?

Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).

Evommune EVMN Invested capital

Discontinued — last reported Q1 '26

Invested capital at other companies

Travel + LeisureTNL

18.8%+0.1pp

BeldenBDC

12.2%+0.5pp

Cabot CorporationCBT

14.7%-6.0pp

UnifirstUNF

6.2%-0.9pp

Envista Holdings CorporationNVST

3.4%+1.8pp

Liberty Broadband CorporationLBRDK

-0.3%-0.1pp

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+42.8%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Calculated from Evommune ’s reported figures.

$2.0Mtotal debt−$4.5Mtotal stockholders equity−$1.1Mcash and equivalents=-$3.58M

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's invested capital?: Evommune (EVMN) reported invested capital of -$3.58M in Q1 2026.
What is the long-term trend for Evommune 's invested capital?: Over 2 years (2023 to 2025), Evommune 's invested capital has grown at a -33.0% compound annual growth rate (CAGR), from $2.05M to $919.1K.
What does invested capital mean?: Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).